SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000927016-03-002186
Filing Date
2003-04-29
Accepted
2003-04-29 15:55:50
Documents
4
Group Members
EVA HAASKATE BINGHAMSCHRODER INVESTMENT MANAGEMENT LIMITEDTOM DANIEL

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D dsc13da.txt SC 13D/A 30889
3 FORM OF VOTING AGREMENT dex991.txt EX-99.1 11178
4 AGREEMENT REGARDING FILING OF JOINT SCHEDULE 13D dex993.txt EX-99.3 1810
5 POWER OF ATTORNEY dex994.txt EX-99.4 2052
  Complete submission text file 0000927016-03-002186.txt   48400
Mailing Address FIVE ARROWS HOUSE ST SWITHINS LN LONDON EC4N 8NR
Business Address FIVE ARROWS HOUSE ST SWITHINS LN LONDON EC4N 8NR
INTERNATIONAL BIOTECHNOLOGY TRUST PLC (Filed by) CIK: 0000942257 (see all company filings)

 

Mailing Address 1365 MAIN STREET WALTHAM MA 02451
Business Address 1365 MAIN STREET WALTHAM MA 02451 (781) 647-5554
ESSENTIAL THERAPEUTICS INC (Subject) CIK: 0001010915 (see all company filings)

IRS No.: 943186021 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-49784 | Film No.: 03669554
SIC: 2834 Pharmaceutical Preparations